Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation
This article was originally published in The Tan Sheet
Executive Summary
Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg
You may also be interested in...
FTC Consumer Chief Vladeck’s Reputation Precedes Him
David Vladeck's appointment as Federal Trade Commission consumer protection chief could bring tighter enforcement against misleading claims for dietary supplements and other products
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture
FTC Consumer Chief Vladeck’s Reputation Precedes Him
David Vladeck's appointment as Federal Trade Commission consumer protection chief could bring tighter enforcement against misleading claims for dietary supplements and other products